Tianwen Li
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research 14
- MicroRNA in disease regulation 12
- Molecular Biology top 2%
- Circular RNAs in diseases 14
- RNA modifications and cancer 6
- RNA and protein synthesis mechanisms 4
- RNA Research and Splicing 4
- CRISPR and Genetic Engineering 2
-
- Drug Transport and Resistance Mechanisms 2
- Journals
- Cancer Biomarkers (3 papers)Journal of Clinical Laboratory Analysis (3 papers)Cancer Medicine (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Tianwen Li
30 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 2.5k
- Molecular Biology 2.8k
- Renewable Energy, Sustainability and the Environment 70
- Pathology and Forensic Medicine 76
- Immunology 89
Countries citing papers authored by Tianwen Li
This map shows the geographic impact of Tianwen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianwen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianwen Li more than expected).
Fields of papers citing papers by Tianwen Li
This network shows the impact of papers produced by Tianwen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianwen Li. The network helps show where Tianwen Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tianwen Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2023 | 10 | |
| 3 | 2022 | 4 | |
| 4 | 2022 | 29 | |
| 5 | 2022 | 3 | |
| 6 | 2020 | 54 | |
| 7 | 2019 | 163 | |
| 8 | 2019 | 70 | |
| 9 | 2018 | 26 | |
| 10 | 2018 | 190 | |
| 11 | 2017 | 15 | |
| 12 | 2017 | 228 | |
| 13 | 2017 | 320 | |
| 14 | 2017 | 5 | |
| 15 | 2017 | 224 | |
| 16 | 2016 | 4 | |
| 17 | Using circular RNA as a novel type of biomarker in the screening of gastric cancerbreakdown → | 2015 | 652 |
| 18 | 2014 | 22 | |
| 19 | 2012 | 2 | |
| 20 | 2010 | 81 |
About Tianwen Li
Tianwen Li is a scholar working on Cancer Research, Molecular Biology and Pharmaceutical Science, having authored 30 papers that have together received 3.0k indexed citations. Recurring topics across this work include Circular RNAs in diseases (14 papers), Cancer-related molecular mechanisms research (14 papers), MicroRNA in disease regulation (12 papers), RNA modifications and cancer (6 papers), RNA and protein synthesis mechanisms (4 papers), RNA Research and Splicing (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Cancer Research (2.5k citations), Molecular Biology (2.8k citations) and Renewable Energy, Sustainability and the Environment (70 citations). Tianwen Li has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Junming Guo, Bingxiu Xiao, Yongfu Shao, Xiaoyan Mo, Yijing Shen, Linwen Zhu, Liyun Fu, Qianfu Zhao, Huilin Chen and Peifei Li. Their work appears in journals such as Cancer Biomarkers, Journal of Clinical Laboratory Analysis, Cancer Medicine, Journal of Molecular Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.